Guizhou Bailing Group Pharmaceutical Co.,Ltd. Continues to Face Investor Claims, Eligible Investors Can Still Join

Investors who suffered losses can register their claims on the Sina Investor Rights Protection Platform.

1. Initial Court Rulings in Favor of Investors Attorney Liu Peng from Shanghai Huzi Law Firm recently secured another batch of favorable judgments for investors suing Guizhou Bailing Group Pharmaceutical Co.,Ltd. over its misleading earnings forecast. Earlier cases have entered the second trial after the company appealed, with hearings concluded and results pending. However, the lawyer noted that the likelihood of the verdict being overturned is low.

The case stems from a regulatory penalty issued on June 5, 2024. The company failed to disclose its 2023 earnings forecast within the required timeframe, despite reporting an audited net loss of 415 million yuan attributable to shareholders.

Under relevant laws, investors who purchased shares between January 31, 2024, and April 29, 2024, and sold or held them after April 30, 2024, incurring losses, are eligible to participate in the claim. Notably, compensation is only possible through active litigation.

2. Under Regulatory Investigation Beyond the earnings forecast violation, the company is also under investigation for suspected disclosure violations. On November 8, 2024, the China Securities Regulatory Commission (CSRC) initiated a probe into the company.

Historical disclosures reveal persistent financial irregularities. From 2014 to 2024, the company received annual inquiry letters regarding abnormal metrics such as accounts receivable, inventory, revenue, and sales expenses. On August 2, 2024, regulators identified multiple financial violations, including inaccurate expense recognition and material internal control deficiencies, leading to misreported financial data for years.

Investors who bought shares before November 8, 2024, and sold or held them after November 9, 2024, suffering losses, may join the claim pending further regulatory findings.

(Attorney Liu Peng, specializing in securities litigation for 19 years, has successfully represented investors in over 300 listed companies, including cases like China Youth Media and Guohua Online Security, with a 99.2% win rate.)